Aerosolized albuterol improves airway reactivity in infants with acute respiratory failure from respiratory syncytial virus

Pediatric Pulmonology

Volumn 26, Issue 1, 1998, Pages 12-20

  Derish, Melinda ^a,c   Hodge, Glenn ^b   Dunn, Colleen ^b   Ariagno, Ronald ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Albuterol; Bronchiolitis; Forced expiratory flow at functional residual capacity; Infant pulmonary function; Inhalation therapy; Mechanical ventilation; Obstructive airways disease; Respiratory failure; Respiratory syncytial virus

Indexed keywords

BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; RIBAVIRIN; SALBUTAMOL;

ACUTE RESPIRATORY FAILURE; AEROSOL; AIRWAY DYNAMICS; ARTICLE; ARTIFICIAL VENTILATION; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENDOTRACHEAL INTUBATION; FEMALE; FORCED EXPIRATORY FLOW; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; NEBULIZER; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

ACUTE DISEASE; ADRENERGIC BETA-AGONISTS; AEROSOLS; ALBUTEROL; FUNCTIONAL RESIDUAL CAPACITY; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RESPIRATORY MECHANICS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TREATMENT OUTCOME;

EID: 0031903277     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199807)26:1<12::AID-PPUL4>3.0.CO;2-K     Document Type: Article

References (46)

1. Navas L, Wang E, de Carvalho V, Robinson J, and the Pediatric Investigators Collaborative Network on Infections in Canada. Improved outcome of respiratory syncytial virus infection in a high-risk population of Canadian children. J Pediatr. 1992; 121:348-354.
2. Stretton M, Ajizian SJ, Mitchell I, Newth CJL. Intensive care course and outcome of infants infected with respiratory syncytial virus. Pediatr Pulmonol. 1992; 13:143-150.
3. Stokes GM, Milner AD, Hodges IGC, Henry RL, Elphick MC. Nebulised therapy in acute severe bronchiolitis in infancy. Arch Dis Child. 1983; 58:279-283.
4. Prendiville A, Green S, Silverman M. Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax 1987; 42:86-91.
5. Hughes DM, Lesouëf PN, Landau LI. Effect of salbutamol on respiratory mechanics in bronchiolitis. Pediatr Res. 1987; 22:83-86.
6. Ho L, Landau LI, Lesouëf PN. Effect of salbutamol on oxygen saturation in bronchiolitis. Arch Dis Child. 1991; 66:1061-1064.
7. Dawson K, Kennedy D, Asher I, Cooper D, Cooper P, Francis P, Henry R, Le Souef P, Martin J, Masters B, Mellis C, Morton J, Olinsky A, Robertson CF, Robinson PJ, Sly P, Staugas R, Van Asperen P, Pattermore P. Consensus view: The management of acute bronchioitis. J Paediatr Child Health. 1993; 29:335-337.
8. Lenney W, Milner AD. At what age do bronchodilator drugs work? Arch Dis Child. 1978; 53:532-535
9. Tepper RS. Airway reactivity in infants: A positive response to methacholine and metaproterenol. J App Physiol. 1987; 1155-1159.
10. Soto ME, Sly PD, Uren E, Taussig LM, Landau LI. Bronchodilator response during acute viral bronchiolitis in infancy. Pediatr Pulmonol. 1985; 2:85-90.
11. Gadomski AM, Aref GH, El Din OB, El Sawy IH, Khallaf N, Black RE. Oral versus nebulized albuterol in Egypt. J Pediatr. 1994; 124:131-138.
12. Kristjansson S, Carlsen KC, Wennergren G, Strannegard I-L, Carlsen K-H. Nebulised racemic adrenaline in the treatment of acute bronchilitis in infants and toddlers. Arch Dis Child. 1993; 69:650-654.
13. Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, McDowell IW, Li MM. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr. 1991; 118:807-811.
14. Schuh S, Canny G, Reisman JJ, Kerem E, Bentur L, Petric M, Levison H. Nebulized albuterol in acute bronchiolitis. J Pediatr. 1990; 117:633-637.
15. Rutter N, Milner AD, Hiller EJ. Effect of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezy bronchitis. Arch Dis Child. 1975; 50:719-722.
16. Mallory GB, Motoyama EK, Koumbourlis AC, Mutich RL, Nakayama DK. Bronchial reactivity in infants with acute respiratory failure with viral bronchiolitis. Pediatr Pulmonol. 1989; 6:253-259.
17. Hammer J, Numa A, Newth JL. Albuterol responsiveness in infants with respiratory failure caused by respiratory syncytial virus infection. J Pediatr. 1995; 127:485-490.
18. Beardsmore CS, Godfrey S, Silverman M. Forced expiratory flow-volume curves in infants and young children. Eur Respir J. 1989; 2:154s-159s.
19. Frankel LR, Wilson CW, Deniers RR, Parker JR, Lewiston NJ, Stevenson DK, Smith DW. A technique for the administration of ribavirin to mechanically ventilated infants with severe respiratory syncytial virus infection. Crit Care Med. 1987; 15:1051-1054.
20. Bhutani VK, Sivieri EM, Abbasi S, Shatter TH. Evaluation of neonatal pulmonary mechanics and energetics: A two factor least mean square analysis, Pediatr Pulmonol. 1988; 4:150-158.
21. 2 clearance curves. J Clin Invest. 1952; 31:40-50.
22. Tepper RS, Morgan WJ, Cota K, Wright A, Taussig LM, Physiologic growth and development of the lung during the first year of life. Am Rev Resp Dis. 1986; 134:513-519.
23. LeSouëf, Castile R, Turner DJ, Motoyama, Morgan WJ. Forced expiratory manuvers. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, eds. Infant Respiratory Function Testing. New York, Wiley-Liss, 1996:379-409.
24. Morgan WJ, Geller DE, Tepper RS, Taussig L. Partial expiratory flow-volume curves in infants and young children. Pediatr Pulmonol. 1988; 5:232-243.
25. LeSouëf PN, Hughes DM, Landau LI. Shape of forced expiratory flow-volume curves in infants. Am Rev Resp Dis. 1988; 138:590-597.
26. Sly PD, Lanteri CJ, Raven JM. Do wheezy infants recovering from bronchiolitis respond to salbutamol? Pediatr Pulmonol. 1991; 13:143-150.
27. Smith DW, Rector DM, Derish MT, Frankel LR, Ariagno RL. Pulmonary function testing in infants with respiratory syncytial virus bronchiolitis requiring mechanical ventilation. Pediatr Infect Dis. J 1990; 9:S108-S111.
28. Smith DW, Rector DM, Frankel LR, Mathers LH, Thomas MS, Derish MT, Ariagno RL. Pulmonary function in children without lung disease requiring mechanical ventilation (Abstract). Am Rev Respir Dis. 1990; 141:A287.
29. Adler SM, Wohl MEB. Flow volume relationship at low lung volumes in healthy newborn infants. Pediatrics 1978; 61:636-640.
30. Taussig LM, Lanadau LI, Godfrey S, Arad I. Determinants of forced expiratory flow in normal newborn infants. J Physiol. 1982; 53:1220-1227.
31. Hanrahan J, Silverman M, Tepper RS. Clinical epidemiology and future directions. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, eds. Infant Respiratory Function Testing. New York, Wiley-Liss, 1996:551-562.
32. Godfrey S, Bar-Yishay E, Arad I, Landau LI, Taussig LM. Flow-volume curves in infants with lung disease. Pediatrics. 1983; 72: 517-522.
33. Baraldi E, Filippone M, Trevisanto D, Zanardo V. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med. 1997; 155:149-155.
34. LeSouëf, Castile R, Turner DJ, Motoyama, Morgan WJ. Forced expiratory manuvers. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, eds. Infant Respiratory Function Testing. New York, Wiley-Liss. 1996:380.
35. Hanrahan J, Castille R, Segal M, Weiss S, Speizer F. Pulmonary function measures in healthy infants. Am Rev Resp Dis. 1990; 141:1127-1135.
36. Tepper RS, Reister T. Forced expiratory flows and lung volumes in normal infants. Pediatr Pulmonol. 1993; 15:357-361.
37. American Thoracic Society / European Respiratory Society. Respiratory mechanics in infants: Physiologic evaluation in health and disease. Am Rev Respir Dis. 1993; 147:474-496.
38. Tepper RS, Rosenberg D, Eigen H, Reister T. Bronchodilator responsiveness in infants with bronchiolitis. Pediatr Pulmonol. 1994; 17:81-85.
39. Mallol J, Hibbert ME, Robertson CF, Olinsky A, Phelan PD, Sly PD. Inherent variability of pulmonary function tests in infants with bronchiolitis. Pediatr Pulmonol. 1988; 5:152-157.
40. Stocks J, Sly PD, Tepper RS, WJ Morgan WJ, eds. Infant Respiratory Function Testing. New York, Wiley-Liss, 1996.
41. Nickerson BG, Lernen RJ, Gerdes CB, Wegmann MJ. Within-subject variability and percent change for significance of spirometry in normal subjects and patients with cystic fibrosis. Am Rev Resp Dis. 1980; 122:859-866.
42. Nickerson BG, Durand DJ, Kao LC. Short-term variability of pulmonary function tests in infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 1989:6:36-41.
43. American Academy of Pediatrics, Committee on Infectious Diseases. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics. 1993; 92:501-504.
44. Janai HK, Stutman HR, Zaleska M, Rub B, Eyzaguirre M, Marks MI, Nussbaum E. Ribavirin effects on pulmonary function in young infants with respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J. 1993; 12:214-218.
45. Zucker AR, Meadow WL. Pediatric critical care physicians attitudes about guidelines for the use of ribavirin in critically ill children with respiratory syncytial virus pneumonia. Crit Care Med. 1995; 23:767-772.
46. Hanrahan J, Silverman M, Tepper RS. Clinical epidemiology and future directions. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, eds. Infant Respiratory Function Testing. New York, Wiley-Liss, 1996:551.